Skip to main content

Table 1 Characteristics (mean (standard deviation) or percentage) of the GOLDN Study sample

From: Suggestion for linkage of chromosome 1p35.2 and 3q28 to plasma adiponectin concentrations in the GOLDN Study

  Participants with adiponectin measured at baseline (n = 1121) Participants with adiponectin measured at both baseline and post-fenofibrate trial (n = 859)
Age (years) 48.2 (16.3) 48.3 (15.9)
BMI (kg/m2) 28.3 (5.6) 28.5 (5.5)
Baseline plasma adiponectin (μg/ml)* 7.4 (4.8 – 10.5) 7.2 (4.7 – 10.2)
Post-trial plasma adiponectin (μg/ml)* -- 7.0 (4.5 – 9.9)
Male (%) 48.1 49.6
Center (%)   
   Minnesota 51.3 49.9
   Utah 48.7 51.1
  1. *median (interquartile range)
  2. measured at baseline